(Q37179716)

18 August 2017

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa (English)

1 reference

18 August 2017

anti-retroviral agent

0 references

0 references

3

Linda-Gail Bekker

1 reference

18 August 2017

Richard Kaplan

4

0 references

Catherine Orrell

object named as

Catherine Orrell

series ordinal

6

0 references

Stephen Lawn

series ordinal

1

object named as

Stephen D Lawn

1 reference

18 August 2017

7

Robin Wood

1 reference

18 August 2017

2

Francesca Little

1 reference

18 August 2017

Elizabeth Campbel

5

1 reference

PMCID

3776050

18 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

18 August 2017

1 reference

18 August 2017

23

1 reference

18 August 2017

3

1 reference

18 August 2017

335-342

1 reference

Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Immunological recovery and antiretroviral therapy in HIV-1 infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Mortality and progression to AIDS after starting highly active antiretroviral therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19114870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19114870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAD.0B013E328321823F

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

3776050